riment
effect
swine
industri
past
three
decad
sinc
late
sever
pedv
vaccin
commerci
asian
countri
part
comprehens
approach
diseas
prevent
clinic
impact
pedv
acut
sever
asia
europ
although
use
commerci
vaccin
may
led
declin
preval
diseas
vaccin
induc
complet
protect
current
epidem
pedv
strain
newborn
piglet
pedv
member
genu
alphacoronaviru
famili
coronavirida
larg
envelop
viru
contain
kb
singlestrand
positivesens
rna
genom
encod
three
nonstructur
protein
replicas
four
structur
protein
spike
envelop
membran
nucleocapsid
n
protein
among
structur
protein
protein
type
glycoprotein
present
surfac
virion
play
import
role
viru
attach
cell
receptor
target
induct
neutral
antibodi
harbor
virusneutr
epitop
addit
protein
associ
adapt
virus
growth
cell
cultur
attenu
pedv
virul
natur
host
therefor
protein
pedv
subject
sequenc
divers
investig
aim
understand
genet
phylogenet
relationship
pedv
isol
epidem
statu
pedv
field
sinc
sever
ped
epidem
occur
mani
swineproduc
countri
caus
substanti
financi
loss
domest
swine
industri
korea
sever
acut
diarrhea
outbreak
associ
high
mortal
rate
approxim
occur
neonat
piglet
begin
novemb
subsequ
ped
epidem
affect
piglet
pig
farm
http
wwwkahisgokr
despit
implement
nation
pedv
vaccin
program
prevent
diseas
pig
farm
field
isol
respons
pedv
epidem
genet
antigen
differ
pedv
vaccin
strain
therefor
recent
sever
ped
epidem
emphas
import
establish
effect
diseas
prevent
nationwid
requir
develop
nextgener
vaccin
pedv
recent
highli
virul
pedv
strain
isol
pool
intestin
homogen
sequenti
subject
passag
vero
cell
laboratori
phylogenet
analysi
base
fulllength
pedv
gene
reveal
strain
belong
genogroup
close
phylogenet
relationship
us
pedv
strain
emerg
present
studi
develop
inactiv
korean
pedv
vaccin
assess
efficaci
homolog
pedv
challeng
grow
pig
furthermor
variou
adjuv
evalu
determin
optimum
vaccineadjuv
mixtur
induc
humor
immun
pig
korean
pedv
strain
isol
laboratori
propag
african
green
monkey
kidney
vero
cell
atcc
manassa
va
usa
describ
previous
use
passag
brief
viral
infect
confluent
monolay
vero
cell
wash
phosphatebuff
salin
pb
inocul
pedv
isol
multipl
infect
dulbecco
modifi
eagl
medium
dmem
invitrogen
carlsbad
ca
usa
contain
crystal
trypsin
sigma
st
loui
mo
usa
incub
hour
atmospher
cultur
medium
replac
remov
extracellular
virion
pedvinfect
cell
maintain
monitor
daili
cytopath
effect
cpe
use
microscop
upon
observ
cpe
cultur
flask
subject
three
round
freez
thaw
clarifi
viral
fluid
collect
centrifug
minut
serial
passag
viru
routin
conduct
sixwel
plate
use
sequenti
limit
dilut
cultur
method
passag
aliquot
viru
store
use
pedv
passag
time
isol
use
challeng
strain
viral
rna
extract
aliquot
use
rneasi
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
complet
genom
viru
sequenc
extern
facil
macrogen
inc
seoul
korea
nextgener
sequenc
techniqu
whole
genom
sequenc
compar
follow
pedv
refer
strain
isol
unit
state
genbank
multiplesequ
align
gener
use
clustal
x
result
visual
use
espript
pedv
chemic
inactiv
use
binari
ethyleneimin
bei
brief
viru
obtain
vero
cell
cultur
roller
bottl
three
round
freez
thaw
collect
viral
fluid
clarifi
inactiv
addit
bei
final
concentr
mm
overnight
remain
bei
neutral
addit
sodium
thiosulf
viru
inactiv
verifi
absenc
viral
growth
vero
cell
cultur
experiment
vaccin
prepar
mix
beiinactiv
pedv
commerci
adjuv
accord
manufactur
recommend
adjuv
use
montanid
im
n
vg
pr
im
seppic
pari
franc
montanid
gel
im
gel
montanid
isa
vg
isa
montanid
isa
vg
isa
oilbas
multiphasicemuls
adjuv
nanoparticlebas
imsgel
synthet
polymerbas
aqueou
adjuv
vaccin
formul
use
imsgel
prepar
ad
adjuv
beiinactiv
viral
fluid
final
adjuv
concentr
vv
follow
vortex
room
temperatur
minut
vaccin
formul
use
prepar
emulsifi
inactiv
viral
fluid
equal
volum
adjuv
use
homogen
stirrerpropel
blade
rpm
minut
water
bath
cool
hour
format
wateroilwat
wow
multipl
emuls
confirm
microscopi
adjuv
vaccin
contain
thimeros
prevent
growth
microorgan
asept
transfer
steril
vaccin
vial
store
use
twenti
grow
pig
week
old
purchas
pedvfre
pig
farm
hous
laboratori
anim
facil
anim
plant
quarantin
agenc
accord
institut
anim
care
use
committe
protocol
ethic
approv
number
start
experi
pig
verifi
serolog
neg
pedv
week
acclimat
pig
randomli
divid
four
vaccin
group
four
pig
comingl
two
separ
room
durat
experi
pig
vaccin
group
immun
twice
intramuscularli
interv
ml
experiment
pedv
vaccin
four
remain
contact
pig
vaccin
use
control
day
first
vaccin
pig
challeng
oral
pedv
ml
clinic
sign
pedv
infect
observ
daili
day
clinic
score
determin
base
diarrhea
sever
clinic
sign
healthi
moder
diarrhea
sever
diarrhea
vomit
dehydr
fecal
sampl
collect
daili
durat
challeng
monitor
viral
shed
fece
serum
sampl
immunoserolog
analysi
collect
day
postvaccin
dpv
day
postchalleng
dpc
ie
dpv
serumneutr
antibodi
titer
determin
viru
neutral
vn
test
cell
cultur
plate
briefli
serum
sampl
collect
pig
vaccin
challeng
dilut
twofold
serumfre
dmem
contain
trypsin
mix
equal
volum
viru
suspens
contain
ml
pedv
incub
hour
virusserum
mixtur
ad
confluent
vero
cell
monolay
incub
hour
thereaft
cultur
wash
three
time
pb
contain
trypsin
replenish
viral
growth
medium
incub
hour
vn
titer
establish
reciproc
valu
highest
serum
dilut
inhibit
pedvspecif
cpe
serum
pedvspecif
antibodi
level
measur
indirect
enzymelink
immunosorb
assay
ielisa
commerci
pedv
n
proteinbas
id
screen
pedv
indirect
screen
test
idvet
montpelli
franc
use
ielisa
conduct
accord
manufactur
instruct
optic
densiti
nm
measur
use
enzymelink
immunosorb
assay
elisa
plate
reader
viral
rna
extract
fecal
sampl
use
rneasi
mini
kit
qiagen
accord
manufactur
instruct
minut
famlabel
probe
use
detect
pedv
viclabel
probe
use
detect
intern
control
result
analyz
stepon
plu
softwar
appli
biosystem
result
except
clinic
data
express
mean
deviat
statist
analysi
perform
use
spss
statist
ver
ibm
corp
armonk
ny
usa
elisa
vn
test
differ
experiment
group
analyz
unpair
student
test
oneway
anova
follow
tukey
post
hoc
test
chisquar
fisher
exact
test
employ
compar
viral
shed
fece
experiment
group
time
point
pvalu
consid
indic
statist
signific
complet
genom
isol
compris
nucleotid
determin
nextgener
sequenc
whole
genom
pedv
strain
use
refer
sequenc
close
genet
relationship
isol
assess
whether
pedv
variant
emerg
sequenti
passag
genom
sequenc
compar
us
pedv
strain
pedv
isol
sequenc
homolog
us
pedv
strain
howev
identifi
amino
acid
aa
mutat
includ
aa
delet
gene
isol
fig
determin
passag
delet
aros
viral
rna
isol
passag
screen
revers
transcript
polymeras
chain
reaction
use
pcr
primer
result
show
ed
delet
mutant
emerg
passag
fig
delet
mutat
detect
passag
present
follow
three
passag
moreov
viral
stock
passag
contain
parent
mutant
virus
grow
pig
appar
healthi
clinic
symptom
oral
challeng
protect
efficaci
experiment
vaccin
challeng
virul
homolog
viru
pedv
determin
absenc
clinic
sign
decreas
viral
shed
observ
period
viral
shed
fece
determin
use
commerci
rrtpcr
kit
pig
nonvaccin
control
nvc
group
exhibit
earli
sign
diseas
typic
mild
diarrhea
loss
appetit
mean
clinic
score
dpc
experienc
sever
wateri
diarrhea
vomit
thereaft
mean
clinic
score
fig
imsgeladjuv
vaccin
group
exhibit
similar
clinic
present
nvc
group
contrast
vaccin
group
exhibit
weaker
delay
clinic
sign
mainli
mild
diarrhea
mean
clinic
score
vaccin
group
clinic
diseas
progress
slow
clinic
sever
rel
weak
compar
nvc
group
wateri
diarrhea
eventu
develop
viral
shed
defin
presenc
pedv
rna
detect
rrtpcr
pedv
shed
fece
group
gener
accompani
clinic
sign
diseas
fig
pedv
rna
first
detect
one
four
pig
imsgel
nvc
group
dpc
durat
viral
shed
differ
among
group
group
viral
shed
fece
continu
day
respect
contrast
vaccin
group
nvc
group
viral
shed
fece
observ
end
challeng
experi
viral
shed
rate
differ
significantli
among
group
number
pig
pedvtot
number
fecal
sampl
dpc
p
serum
antibodi
respons
induc
experiment
vaccin
assess
ielisa
vn
experiment
vaccin
induc
signific
pedvspecif
serum
igg
respons
pedv
mean
igg
level
vaccin
group
nvc
group
increas
continu
first
second
vaccin
dpv
mean
igg
level
vaccin
group
significantli
higher
nvc
group
p
unpair
student
test
fig
mean
igg
level
significantli
higher
vaccin
group
imsgeladjuv
vaccin
group
dpv
p
tukey
post
hoc
test
fig
indic
adjuv
induc
strongest
pedvspecif
igg
respons
grow
pig
vn
titer
also
increas
continu
vaccin
group
first
second
vaccin
significantli
higher
nvc
group
p
unpair
student
test
fig
although
maximum
vn
titer
vaccin
group
detect
dpv
signific
differ
among
valu
p
tukey
post
hoc
test
contrast
dpv
mean
vn
titer
group
vn
titer
significantli
higher
vn
titer
im
gel
vn
titer
group
group
also
exhibit
higher
mean
vn
titer
vn
titer
imsgel
group
mean
vn
titer
group
compar
p
tukey
post
hoc
test
fig
find
indic
adjuv
induc
virusneutr
antibodi
respons
fig
clinic
score
viral
shed
pig
challeng
virul
homolog
viru
porcin
epidem
diarrhea
viru
pedv
diarrhea
sever
score
viral
shed
fece
monitor
realtim
revers
transcript
polymeras
chain
reaction
b
letter
bar
indic
signific
differ
among
experiment
group
p
fisher
exact
test
wherea
b
indic
signific
differ
nvc
nonvaccin
control
rapidli
imsgel
adjuv
recent
outbreak
global
reemerg
ped
pose
substanti
threat
swine
industri
asia
unit
state
inde
efficaci
commerci
avail
inactiv
pedv
vaccin
base
strain
use
asian
swineproduc
countri
uncertain
pedv
strain
associ
recent
sever
ped
outbreak
genogroup
thu
antigen
genet
distinct
pedv
vaccin
strain
may
explain
low
protect
efficaci
pedv
vaccin
outbreak
strain
suggest
develop
efficaci
vaccin
urgent
requir
virul
korean
pedv
strain
recent
isol
passag
laboratori
isol
almost
genet
ident
pedv
strain
respons
sever
ped
epidem
asia
unit
state
sinc
genogroup
therefor
suitabl
candid
develop
inactiv
vaccin
current
epidem
pedv
strain
adapt
virus
cell
cultur
passag
use
alter
mechan
viral
replic
instanc
wildtyp
hepat
viru
hav
produc
low
yield
progeni
viru
due
low
replic
capac
cellcultureadapt
hav
variant
gener
repeat
passag
produc
higher
titer
infecti
viral
particl
compar
studi
grow
pig
vaccin
inactiv
pedv
vaccin
report
humor
immun
respons
increas
increas
viral
titer
inocul
therefor
cell
cultureadapt
viral
variant
yield
higher
titer
use
develop
inactiv
viral
vaccin
end
passag
isol
time
vero
cell
interv
growth
kinet
analysi
show
viru
neutral
vn
test
c
pedvspecif
igg
virusneutr
antibodi
titer
respect
bar
repres
mean
standard
deviat
five
independ
sampl
indic
signific
differ
nonvaccin
control
nvc
group
p
p
p
respect
unpair
student
test
differ
lowercas
letter
bar
indic
signific
differ
among
group
p
tukey
post
hoc
test
infecti
titer
increas
significantli
passag
indic
viru
acquir
adapt
mutat
enhanc
product
infecti
viru
investig
underli
mechan
analyz
whole
genom
nextgener
sequenc
compar
refer
genogroup
pedv
adapt
genom
harbor
mutat
gene
encod
structur
nonstructur
protein
among
mutat
remark
aa
delet
region
nonstructur
protein
hypothes
aa
delet
reduc
durat
replic
cycl
find
support
previou
report
twothird
coronaviru
genom
contain
orf
encod
viral
rna
replicas
pregnant
sow
suitabl
model
evalu
effect
inactiv
pedv
vaccin
target
popul
neonat
piglet
transfer
matern
antibodi
piglet
via
colostrum
may
play
import
role
develop
protect
immun
pedv
suck
piglet
howev
consider
size
litter
hous
reproduct
limit
use
vaccin
experi
correspondingli
higher
cost
associ
hous
experiment
need
therefor
present
studi
use
grow
pig
evalu
protect
efficaci
experiment
vaccin
pig
age
suscept
pedv
infect
variou
type
adjuv
use
inactiv
viral
vaccin
induc
protect
immun
respons
therefor
determin
optimum
adjuv
particular
vaccin
import
studi
compar
abil
experiment
vaccin
formul
four
adjuv
induc
protect
immun
pedv
although
none
vaccin
pig
complet
protect
subsequ
viral
challeng
develop
significantli
stronger
immun
respons
nvc
pig
strongest
antibodi
respons
detect
pig
receiv
vaccin
contain
oilbas
wow
emuls
adjuv
vaccin
protect
diseas
progress
viral
shed
similarli
foot
mouth
diseas
vaccin
formul
elicit
strongest
antibodi
respons
induc
protect
diseas
formul
also
elicit
protect
immun
viral
bacteri
pathogen
variou
mammalian
speci
although
emulsifi
adjuv
frequent
use
veterinari
vaccin
instead
aluminum
hydroxid
induc
longterm
immun
improv
adjuv
base
nanoparticl
polym
requir
imsgel
aqueou
adjuv
compos
nanoparticl
immunostimulatori
compound
synthet
polym
respect
http
wwwseppiccom
accord
manufactur
adjuv
significantli
enhanc
strength
durat
immun
respons
suitabl
wide
rang
infecti
agent
inde
abil
adjuv
induc
specif
mucos
immun
variou
pathogen
target
anim
assess
studi
pig
receiv
vaccin
contain
imsgel
exhibit
strong
serum
pedvspecif
antibodi
respons
summari
novel
inactiv
pedv
vaccin
formul
wow
emuls
adjuv
immunogen
effect
grow
pig
find
support
use
grow
pig
altern
experiment
model
assess
protect
efficaci
inactiv
pedv
vaccin
pregnant
sow
neonat
piglet
therefor
result
may
use
reduc
risk
failur
futur
clinic
trial
pedv
vaccin
matern
deriv
lactogen
immun
igg
iga
play
import
role
protect
neonat
piglet
pedv
infect
thu
futur
studi
assess
effect
vaccin
sow
novel
inactiv
pedv
vaccin
neonat
piglet
